Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Dec 23 2020

Full Issue

Walmart Sued By Government Over Opioids

The civil lawsuit against the giant retailer claims the company's pharmacies fueled the opioid crisis by not giving its pharmacists the authority to refuse to fill prescriptions from known "pill mills."

AP: Feds Sue Walmart Over Role In Opioid Crisis

The Justice Department sued Walmart on Tuesday, accusing it of fueling the nation’s opioid crisis by pressuring its pharmacies to fill even potentially suspicious prescriptions for the powerful painkillers. The civil complaint filed points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and Walmart’s own responsibility for the allegedly illegal distribution of controlled substances to the pharmacies at the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country. (Balsamo and D'Innocenzio, 12/22)

Modern Healthcare: Walmart Ignored Red Flags In Illegitimate Opioid Prescription Orders, Feds Allege

Managers across Walmart's 5,000 U.S pharmacies denied its pharmacists the authority to refuse to fill prescriptions from known "pill mills" and withheld related compliance data from their workers, federal regulators alleged in the complaint filed in federal court. While Walmart stopped distributing controlled substances in 2018, it had received hundreds of thousands of suspicious orders that it failed to report to the Drug Enforcement Agency, according to the lawsuit, which is seeking what could be billions of dollars in damages and limitations on its prescribing privileges. (Kacik, 12/22)

The New York Times: Justice Department Sues Walmart, Saying It Fueled Opioid Crisis 

The 160-page civil complaint alleges that Walmart knew its system for detecting questionable prescriptions was inadequate and details numerous instances when employees warned federal authorities and company managers about suspicious prescriptions. “As one of the largest pharmacy chains and wholesale drug distributors in the country, Walmart had the responsibility and the means to help prevent the diversion of prescription opioids,” Jeffrey Bossert Clark, acting assistant attorney general of the Justice Department’s civil division, said in a statement. “Instead, for years, it did the opposite — filling thousands of invalid prescriptions at its pharmacies and failing to report suspicious orders of opioids and other drugs placed by those pharmacies.” (Benner and Corkery, 12/22)

NPR: Walmart Sued Over Its Alleged Role In The Opioid Crisis

If the retailer is found liable in the case, it could face civil penalties of up to $67,627 for each unlawful prescription filled and $15,691 for each suspicious order not reported. The case, which the department says was the result of a multi-year investigation, was filed in federal court in Delaware. The complaint alleges that Walmart violated the Controlled Substances Act in multiple ways, as the operator of both pharmacies and wholesale drug distribution centers. (Wamsley, 12/22)

In related news from West Virginia —

AP: WVa, Others To Get $1.85M In Federal Opioid Misuse Funding

West Virginia’s U.S. senators announced $1.85 million in federal funding for opioid misuse research and treatment programs in the state. The bulk of the money, $1.53 million, will go to the West Virginia Department of Health and Human Resources. West Virginia University will also get $222,500 for drug abuse and addiction research. (12/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF